首页> 外文期刊>Infection and immunity >DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis
【24h】

DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis

机译:表达组织纤溶酶原激活物信号序列融合蛋白或泛素结合抗原的DNA疫苗组合在肺结核小鼠模型中诱导持续的保护性免疫。

获取原文
           

摘要

DNA vaccination has emerged as a powerful approach in the search for a more efficacious vaccine against tuberculosis. In this study, we evaluated the effectiveness of immunizing with combinations of 10 different tuberculosis DNA vaccines that expressed mycobacterial proteins fused at the N terminus to eukaryotic intracellular targeting sequences. In one vaccine combination, the genes were fused to the tissue plasminogen activator signal sequence (TPA), while in a second combination the same 10 genes were expressed as ubiquitin (Ub)-conjugated proteins. In ex vivo studies in which the secretion of gamma interferon was measured, cellular immune responses were detected in mice vaccinated with either the TPA DNA vaccine combination or the Ub DNA vaccine combination at 7 and 14 days following a low-dose Mycobacterium tuberculosis challenge. Moreover, mice vaccinated with the TPA combination, the Ub combination, and Mycobacterium bovis BCG were able to limit the growth of tubercle bacilli in the lung and spleen after a virulent tuberculous aerosol challenge. Histopathological analyses also showed that mice immunized with the DNA vaccine combinations had substantially improved postinfection lung pathology relative to the na?ve controls. Finally, in three different long-term experiments, the survival periods following aerogenic challenge were extended as much as sevenfold for vaccinated mice compared to na?ve controls. Interestingly, in all three experiments, no significant differences were detected in the mean times to death for mice immunized with the TPA combination or the Ub combination relative to the BCG controls. In conclusion, these studies demonstrate the effectiveness of immunization with DNA vaccine combinations against tuberculosis and suggest that further testing of these plasmid cocktails is warranted.
机译:在寻找更有效的抗结核疫苗时,DNA疫苗已成为一种强有力的方法。在这项研究中,我们评估了10种不同结核病DNA疫苗的组合免疫效果,这些疫苗表达了在N末端融合到真核细胞内靶向序列的分枝杆菌蛋白。在一种疫苗组合中,这些基因与组织纤溶酶原激活物信号序列(TPA)融合,而在第二种组合中,相同的10个基因被表达为泛素(Ub)偶联蛋白。在测量γ干扰素分泌的离体研究中,在小剂量结核分枝杆菌接种后第7天和第14天,在接种了TPA DNA疫苗组合或Ub DNA疫苗组合的小鼠中检测到细胞免疫应答挑战。而且,用强效结核菌气溶胶激发后,用TPA组合,Ub组合和牛分枝杆菌BCG接种的小鼠能够限制肺和脾中结核杆菌的生长。组织病理学分析还显示,与纯天然对照组相比,用DNA疫苗组合免疫的小鼠感染后的肺部病理学已大大改善。最后,在三个不同的长期实验中,与单纯对照组相比,接种疫苗的小鼠在进行气源性攻击后的存活期延长了七倍。有趣的是,在所有三个实验中,相对于BCG对照,用TPA组合或Ub组合免疫的小鼠的平均死亡时间未检测到显着差异。总之,这些研究证明了用DNA疫苗组合免疫结核病的有效性,并建议对这些质粒混合物进行进一步测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号